Duffy Null–Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility

IF 20.1 1区医学 Q1 ONCOLOGY

JAMA Oncology Pub Date : 2025-10-09 DOI:10.1001/jamaoncol.2025.3869

Lauren E. Merz, Yating Wang, Angel Cronin, Elad Sharon, Thomas P. Walsh, Stephen P. Hibbs, Christopher S. Lathan, Andrew Hantel

引用次数: 0

Abstract

This cross-sectional study examines absolute neutrophil count–related racial and ethnic disparities in cancer clinical trial eligibility using Duffy null status.

查看原文本刊更多论文

Duffy零相关绝对中性粒细胞计数和癌症临床试验资格

本横断面研究使用Duffy无效状态检查绝对中性粒细胞计数与癌症临床试验资格的种族和民族差异。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAMA Oncology Medicine-Oncology

自引率

1.80%

发文量

423

期刊介绍： JAMA Oncology is an international peer-reviewed journal that serves as the leading publication for scientists, clinicians, and trainees working in the field of oncology. It is part of the JAMA Network, a collection of peer-reviewed medical and specialty publications.